• Western blot analysis of lysates from Jarkat cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-TNFRSF13C antibody (STJ192022)

SKU:
STJ192022

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Tumor necrosis factor receptor superfamily member 13C is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: TNFRSF13C
Gene ID: 115650
Uniprot ID: TR13C_HUMAN
Specificity: TR13C Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from part of the human protein
Function B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response.
Protein Name Tumor Necrosis Factor Receptor Superfamily Member 13c
B-Cell-Activating Factor Receptor
Baff Receptor
Baff-R
Blys Receptor 3
Cd Antigen Cd268
Database Links Reactome: R-HSA-5668541
Reactome: R-HSA-5676594
Cellular Localisation Membrane
Single-Pass Type Iii Membrane Protein
Alternative Antibody Names Anti-Tumor Necrosis Factor Receptor Superfamily Member 13c antibody
Anti-B-Cell-Activating Factor Receptor antibody
Anti-Baff Receptor antibody
Anti-Baff-R antibody
Anti-Blys Receptor 3 antibody
Anti-Cd Antigen Cd268 antibody
Anti-TNFRSF13C antibody
Anti-BAFFR antibody
Anti-BR3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance